Historical version

This is version 1, as it stood on . It is not what this organization currently publishes — read the current version.

Anvisa aprova primeiro medicamento de GLP-1 oral para obesidade

Imported from official source

Produto é indicado para perda e manutenção do peso em adultos

This version

Version
1 of 2
Recorded
November 04, 2026 09:01
Change
Initial
Content hash
e9bd466f294227e690268e3f4d5e1e65
All versions
Revision history

Officially records where a publication came from, not whether it is true. Imported records are reproduced from an organization's own official source.